Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
IMCAS World CongressIMCAS World Congress
Not Confirmed
Not Confirmed
29-31 January, 2026
IMCAS World CongressIMCAS World Congress
Not Confirmed
Not Confirmed
29-31 January, 2026
34th NZW-Hamburg34th NZW-Hamburg
Not Confirmed
Not Confirmed
30 January-01 February, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
IMCAS World CongressIMCAS World Congress
Industry Trade Show
Not Confirmed
29-31 January, 2026
IMCAS World CongressIMCAS World Congress
Industry Trade Show
Not Confirmed
29-31 January, 2026
34th NZW-Hamburg34th NZW-Hamburg
Industry Trade Show
Not Confirmed
30 January-01 February, 2026
Digital content

08 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/new-subgroup-analyses-from-landmark-phase-3-aspen-study-of-brensocatib-in-patients-with-bronchiectasis-demonstrate-consistency-with-positive-overall-trial-population-results-302270626.html
Services
Drug Product Manufacturing
ABOUT THIS PAGE
Mars Therapeutics is a supplier offers 1 products (APIs, Excipients or Intermediates).
Find a price of Metformin bulk offered by Mars Therapeutics